Patents by Inventor Laboratoire HRA-PHARMA

Laboratoire HRA-PHARMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING UTERINE FIBROIDS
    Publication number: 20130023506
    Abstract: The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17?-acetoxy-11?-[4-N,N-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids.
    Type: Application
    Filed: September 19, 2012
    Publication date: January 24, 2013
    Applicants: The United States of America, as represented by the Secretary, Dept. of Health and Human Services, Laboratoire HRA-PHARMA
    Inventors: Laboratoire HRA-PHARMA, The United States of America, as represented by the Secretary, Dept. of Health and Human Services